Filtered by:
37 Programs
-
Interview and Lecture
Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer
-
-
E
-
E
-
-
E
-
E
-
-
Webinar Proceedings
Current and Future Integration of Antibody-Drug Conjugates into the Management of Metastatic Breast Cancer
-
-
A
-
A
-
A
-
-
5-Minute Journal Club
Defining the Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Breast Cancer — Issue 4
-
-
K
-
K
-
-
Webinar Proceedings
The Implications of Recent Datasets for the Current and Future Management of Breast Cancer — An ASCO 2025 Review
-
-
S
-
S
-
S
-
-
S
-
S
-
S
-